Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 5 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Sarcoma, Ewing 1 SCLC 1 Retinoblastoma 1 Osteosarcoma 1 Oligometastatic Disease 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Lymphoma, Follicular 1 Lymphoma 1 Locally Advanced Resectable Rectal Cancer 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1

Interventions

Vincristine 1 Topotecan 1 Platinum Compounds 1 Melphalan 1 Hyperthermia, Induced 1 Etoposide 1 Drug Therapy 1 Cryotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Retinoblastoma × Drug Therapy × Clear all

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡